Synopsis
It has been well known that the virilization of female offsprings is caused after the maternal administration of some synthetic steroids (Moncriff et al., 1958; Wilkins, 1960; Revesz et al., 1960; Falconi et al., 1961; Suchowsky et al., 1961 and 1967; Lerner et al., 1962; Neumann and Junkmann, 1963) . Although early workers estimated the activities rather qualitatively by indirect technique (Neumann and Junkmann, 1963; Neumann and Kramer, 1964; Falconi and Rossi, 1965) , a new method for the estimation of virilizing activity by measuring the morphological changes in the pelvic region of the female rat fetus directly under microscope was proposed and the virilizing activities of methyltestosterone and norethandrolone were estimated quantitatively in the previous report (Kawashima et al., 1975 The day of as the first day of gestation. The pregnant rats were treated orally with steroids for 4 days from the 17th to the 20th day of gestation.
The steroids examined are shown in Table 1 . Steroids were dissolved in 0.2ml of olive oil with exceptions of progesterone and retroprogesterone which were dissolved in 1ml of olive oil. Control rats were treated with olive oil. On the 21st day of gestation, the fetuses were removed from their mother under ether anesthesia and were fixed with 10% neutral formalin solution for 2 weeks. Sagittal serial sections of the pelvic region of female fetus were prepared and urovaginal septum length was measured directly under microscope equipped with a micrometer as described previously (Kawashima et al., 1975) .
Results

Progesterone derivatives
Oral administration of progesterone did not affect the urovaginal septum length with as high dose level as 200mg (Table  2) . Chlormadinone acetate and retroprogesterone caused no changes in the urovaginal septum length when the daily doses of 10 and 50mg were used, respectively. While, highly significant abridgments in the septum length were observed in the fetuses receiving medroxyprogesterone at the dose level of 1mg and megestrol acetate of 5mg. 19-Nortestosterone derivatives Significant abridgments in the urovaginal septum length were noticed at a daily dose of 5mg in all steroids examined with an exception of nandrolone phenpropionate which showed no virilizing activity even at the dose level of 10mg (Table 4) . Among these steroids norethandrolone and 
Discussion
The inhibitory effect of testosterone on fetal urovaginal septum devolopment was examined chronologically after a single dose of 5mg/rat of testosterone on days 16, 17, 18, 19 or 20 of gestation, and critical day was found at the 19th day of gestation (Kawashima et al., 1977) . But, consecutive daily doses of as low as 0.01mg/rat of the drug for 4 days from the 17th to 20th day caused more striking abridgment than observed in single administration.
These results show that a single dose of testosterone before urovaginal septum development did not cause a full abridgment of this region, but an abridgment was enhanced by consecutive lower doses of testosterone during urovaginal septum development. On the basis of these findings the virilizing activities of steroids were examined after consecutive administrations of the drugs.
No fetal virilizing activity was observed with oral progesterone even as large daily dose as 200mg/day.
And also, retroprogesterone showed no virilizing activity at a dose level of 50mg/day, though the oral doses of some retroisomer of progesterone has been reported to produce a greater deciduoma-inducing activity in female rat than the parent compound (Krause, 1971) . Furthermore, it was reported that subcutaneous administration of 100mg or 200mg/day of progesterone or of 10 to 30mg/day of retro-6-dehydroprogesterone did not cause virilization in female rat fetuses as judged by the indirect measurements of the abridgment in urovaginal septum length (Suchowsky et al., 1967) and by the macroscopic measurement of anogenital distance (Revesz et al., 1960; Scholer and deWachter, 1961 
